{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_3", "age_group": "31_40", "agreed": true, "close_date_time": "2021-10-16 11:3:28", "close_timestamp": 1637060608899, "created": "16/11/2021 11:03:29", "department": "English and Creative Writing ", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "female", "id": "ffb19de0-8699-417d-8652-f687417e1bc4", "open_date_time": "2021-10-16 10:58:36", "open_timestamp": 1637060316627, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "Dr Kylie Wagstaff introduced new anti-virus research,  arguing that this can kill the Covid-19 virus. ", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_phd", "time_taken_in_seconds": 292272, "what": " ivermectin is a useful drug to kill Covid virus. ", "when_happened": "current_month", "where_location": "Monash University", "who": "Dr Kylie Wagstaff", "why": "it is an anti-virus research "}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_3", "age_group": "31_40", "agreed": true, "close_date_time": "2021-10-16 11:14:43", "close_timestamp": 1637061283433, "created": "16/11/2021 11:14:45", "department": "English and Creative Writing ", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "female", "id": "efff8dff-e09e-4748-baa0-4bd38f660313", "open_date_time": "2021-10-16 11:9:18", "open_timestamp": 1637060958820, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "The news source has shown there is no worry about the supply of vaccination, and in fact, that vaccination can be used in other countries for a huger impact. ", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_phd", "time_taken_in_seconds": 324613, "what": "there are still plentiful supply of vaccination can be used alternatively ", "when_happened": "current_month", "where_location": "America ", "who": "Vaccination Company ", "why": "it is about the supply of vaccination "}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_3", "age_group": "31_40", "agreed": true, "close_date_time": "2021-10-16 11:8:55", "close_timestamp": 1637060935212, "created": "16/11/2021 11:08:55", "department": "English and Creative Writing ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "female", "id": "daf35675-743c-4c90-b40e-322e901d9833", "open_date_time": "2021-10-16 11:3:45", "open_timestamp": 1637060625260, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Even though the pandemic situation is not getting any easy, but Australian medication expert finds a safer and faster medication method to kill the virus. ", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_phd", "time_taken_in_seconds": 309952, "what": "Australia GP urges the public to take the third therapy, however, some people believe a more traditional but safer medication option. ", "when_happened": "current_month", "where_location": "Australia ", "who": "Australia GP ", "why": "It is related to Covid "}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_3", "age_group": "31_40", "agreed": true, "close_date_time": "2021-10-16 10:58:9", "close_timestamp": 1637060289017, "created": "16/11/2021 10:58:11", "department": "English and Creative Writing ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "female", "id": "36207991-c29a-4526-9e25-9af4b833445d", "open_date_time": "2021-10-16 10:52:57", "open_timestamp": 1637059977859, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "Japan approves new treatment for Covid-19, which is believed to reduce hospitalisation and death. This is particularly helpful for the emerging Delta variant. ", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_phd", "time_taken_in_seconds": 311158, "what": "Japan approves a new treatment ", "when_happened": "current_week", "where_location": "Japan ", "who": "Japan ", "why": "it helps to reduce hospitalisation and death "}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_3", "age_group": "31_40", "agreed": true, "close_date_time": "2021-10-16 11:34:35", "close_timestamp": 1637062475295, "created": "16/11/2021 11:34:37", "department": "English and Creative Writing ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "female", "id": "ae171678-1306-452b-8310-9c692c11a6d8", "open_date_time": "2021-10-16 11:28:5", "open_timestamp": 1637062085628, "summary": "I had a quick scan of the news related to the topic of Pfizer, surprisingly, more positive reports were given about this topic. It shows that it can be very effective when dealing with Delta variants, and it has been used recently for adolescents. I didn't see too many discussions and reports about its potential risks and concerns, and to be fair, they are more like the advertisement promotion about this vaccination company. One headline that caught my attention is that excessive vaccination will be used (perhaps donated) in African counties, and it is really a good public relations strategy. ", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_phd", "time_taken_in_seconds": 389667}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_3", "age_group": "31_40", "agreed": true, "close_date_time": "2021-10-16 11:27:37", "close_timestamp": 1637062057005, "created": "16/11/2021 11:27:38", "department": "English and Creative Writing ", "disability": false, "ease": 1, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "female", "id": "287b04b1-5598-4381-88b2-be4bc7cd168a", "open_date_time": "2021-10-16 11:15:15", "open_timestamp": 1637061315642, "summary": "Based on the media discourse, the risks and concerns about vaccination have been discussed globally, from India to China. When the pandemic situation develops, more dramatic incidents have happened. For example, the USA has excessive supplies of vaccination, while the UK holds a certain trust crisis with the medicine developing companies. It seems that even though the positive aspects of vaccination have been established through the authoritative source, however, the world seems to be still haunted by enormous emotions of distrust and suspect. It is sad.  ", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_phd", "time_taken_in_seconds": 741363}}}